For 20 years, dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a
platelet P2Y12 receptor inhibitor, has been the gold standard of antithrombotic …

Objectives The aim of this study was to compare short dual antiplatelet therapy (DAPT) and
de-escalation in a network meta-analysis using standard DAPT as common comparator …

Importance Acute coronary syndrome (ACS) is a major cause of morbidity and mortality in
the United States with an annual incidence of approximately 1 million. Dual antiplatelet …

OBJECTIVE In recent years, some studies have indicated that a novel marker described as
the stress hyperglycemia ratio (SHR) can reflect true acute hyperglycemic status and is …

Background: High-sensitivity cardiac troponin assays enable myocardial infarction to be
ruled out earlier, but the safety and efficacy of this approach is uncertain. We investigated …

Objectives The aim of this study is to compare the image quality of in vivo coronary stents
between an energy integrating detectors dual-layer computed tomography (EID-DLCT) and …

After ischemic stroke, there is a significant burden of cardiovascular complications, both in
the acute and chronic phase. Severe adverse cardiac events occur in 10% to 20% of …

Aims To provide multi-national, multi-ethnic data on the clinical characteristics and
prognosis of patients with microvascular angina (MVA). Methods and results The Coronary …

Objectives The aim of this study was to examine the effect of CYP2C19 genotype on clinical
outcomes in patients with coronary artery disease (CAD) who predominantly underwent …

Aims The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary
intervention (PCI) in patients at high bleeding risk (HBR) is still debated. The current study …